These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12689599)
41. Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease. Inspector M; Aharon-Perez J; Glass-Marmor L; Miller A Eur Neurol; 2005; 53(3):155-7. PubMed ID: 15942243 [No Abstract] [Full Text] [Related]
42. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497 [TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis. Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814 [TBL] [Abstract][Full Text] [Related]
44. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy. Abu El-Asrar AM; Ahmad A; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G Acta Ophthalmol; 2018 Feb; 96(1):e27-e37. PubMed ID: 28391660 [TBL] [Abstract][Full Text] [Related]
45. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9? van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037 [TBL] [Abstract][Full Text] [Related]
46. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Li H; Simon H; Bocan TM; Peterson JT Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234 [TBL] [Abstract][Full Text] [Related]
47. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta. Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833 [TBL] [Abstract][Full Text] [Related]
48. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704 [TBL] [Abstract][Full Text] [Related]
49. Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction. Muniz JJ; Lacchini R; Belo VA; Nobre YT; Tucci S; Martins AC; Tanus-Santos JE Int J Impot Res; 2012; 24(1):38-43. PubMed ID: 21918531 [TBL] [Abstract][Full Text] [Related]
50. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Hoffmann U; Bertsch T; Dvortsak E; Liebetrau C; Lang S; Liebe V; Huhle G; Borggrefe M; Brueckmann M Scand J Infect Dis; 2006; 38(10):867-72. PubMed ID: 17008230 [TBL] [Abstract][Full Text] [Related]
51. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. Ichiyama T; Kajimoto M; Suenaga N; Maeba S; Matsubara T; Furukawa S J Neuroimmunol; 2006 Mar; 172(1-2):182-6. PubMed ID: 16321449 [TBL] [Abstract][Full Text] [Related]
52. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure. George J; Patal S; Wexler D; Roth A; Sheps D; Keren G Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329 [TBL] [Abstract][Full Text] [Related]
54. Sex-specific associations of matrix metalloproteinases in Alzheimer's disease. Aksnes M; Edwin TH; Saltvedt I; Eldholm RS; Chaudhry FA; Halaas NB; Myrstad M; Watne LO; Knapskog AB Biol Sex Differ; 2023 May; 14(1):35. PubMed ID: 37221606 [TBL] [Abstract][Full Text] [Related]
55. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Głowińska-Olszewska B; Urban M Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313 [TBL] [Abstract][Full Text] [Related]
56. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401 [TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants. Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598 [TBL] [Abstract][Full Text] [Related]